Introduction to the economics of health promotion and disease prevention by Sassi, Franco et al.
  
Franco Sassi, David McDaid and Sherry Merkur    
Introduction to the economics of health 
promotion and disease prevention 
 
Book section 
(Published version) 
 
 
 
 
Original citation: Originally published in: McDaid, David, Sassi, Franco and Merkur, Sherry, 
(eds.) Promoting Health, Preventing Disease: The Economic Case. UK higher education 
humanities & social sciences health & social welfare. Maidenhead, UK : Open University Press, 
2015, pp. 3-18.  
 
 
© 2015 World Health Organization 
 
This version available at: http://eprints.lse.ac.uk/62734/ 
Available in LSE Research Online: July 2016 
 
 
LSE has developed LSE Research Online so that users may access research output of the 
School. Copyright © and Moral Rights for the papers on this site are retained by the individual 
authors and/or other copyright owners. Users may download and/or print one copy of any 
article(s) in LSE Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities 
or any commercial gain. You may freely distribute the URL (http://eprints.lse.ac.uk) of the LSE 
Research Online website.  
 
This document is the author’s submitted version of the book section. There may be differences 
between this version and the published version.  You are advised to consult the publisher’s 
version if you wish to cite from it. 
 
 
chapter one
Introduction to the economics 
of health promotion and disease 
prevention
Franco Sassi, Sherry Merkur and  
David McDaid
Economics, health promotion and disease prevention
This book is designed to provide an economic perspective on health promotion 
and chronic disease prevention. The book includes a framework for analysing 
the consequences of prevention strategies, which draws from disciplines such 
as psychology, sociology, epidemiology, and public health, in addition to 
economics. It also provides a compendium of evidence of the economic impacts 
of a range of policy interventions in a number of core areas of public health 
action. The approach builds on the hypothesis that countering the epidemic 
of chronic diseases that countries in Europe and elsewhere are experiencing 
with appropriate prevention strategies would provide the means for better 
increasing social welfare and/or enhancing health equity, compared with 
not taking preventive actions and simply treating chronic diseases once they 
emerge.
An economic perspective is about more than counting the costs associated 
with diseases, whether medical care costs or productivity losses. And, it 
involves more than assessing the cost- effectiveness of preventive interventions, 
although the latter is an important role for health economics. The potential for 
an economic approach to shape and inform the debate on prevention stretches 
beyond those aspects. Economics contributes to our understanding of the 
pathways through which chronic diseases are generated and of the choices and 
behaviours involved in those pathways. It provides the tools for developing 
effective and efficient policy strategies and addressing potential trade- offs 
between the goals of increasing social welfare and improving the distribution 
of health across individuals and population groups.
This book is designed for a broad audience of health policy makers, national 
and local, in countries at all levels of income; for public health practitioners and 
advocates; and for scholars in a number of relevant disciplines, ranging from 
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health economics to sociology, political science, medicine and public health. It 
is meant to provide those audiences with a comprehensive view of the current 
evidence base in support of a broad range of public health interventions, 
addressing not only their effectiveness in improving population health, but also 
their implementation costs, impacts on health expenditures, and other economic 
consequences. Individual chapters provide critical reviews of the evidence 
base in specific areas, with a view to assessing the validity of the evidence and 
its generalizability to different settings. The geographical perspective of this 
book is that of the World Health Organization’s (WHO’s) European Region, but 
its scope stretches more widely, as evidence is reported and reviewed from 
studies undertaken in many countries, within and outside Europe.
The scope of the book
The field of health promotion and disease prevention is potentially vast, and in 
no way could this book have covered it comprehensively. A number of choices 
had to be made on the scope covered. The first one was about the health 
promotion and prevention interventions to be assessed. The book deals with 
interventions for the prevention of chronic noncommunicable diseases (NCDs), 
and certain types of injuries, while it does not cover the prevention of infectious 
diseases or their chronic sequelae. The choice was driven by the prominence 
that NCDs have acquired in many countries, due to their large and increasing 
disease burden, discussed later in this chapter. Correspondingly, the relative 
weight of infectious diseases has progressively decreased.
Much of the prevention of chronic NCDs is based on tackling behavioural 
risk factors, which are key determinants of those diseases. These include, in 
particular, tobacco smoking, harmful alcohol use, unhealthy diets, lack of 
physical activity, and other health- related behaviours. Several chapters later 
in the book address specific risk factor areas, focusing on the interventions 
available to prevent diseases by eliminating, or containing the impacts of, those 
risk factors.
Health- related behaviours are the dominant, albeit not exclusive, focus. This 
implies that the types of interventions reviewed are mostly those designed 
for healthy people with risk factors, and aimed at steering their behaviours 
towards healthier patterns. These interventions are often delivered outside 
the health care system, using resources from different areas of government 
spending. Less attention is devoted to the many forms of prevention that 
are typically delivered within the health care system, such as screening 
programmes, or pharmacological prevention (e.g. with statins, or anti- 
hypertensive medications), which of course are no less important than more 
upstream actions, but have been studied much more extensively than the latter.
Finally, the book takes primarily a government policy perspective, based 
on the argument developed later in this chapter that prevention is a legitimate 
area for government intervention because of market and rationality failures 
that would otherwise prevent individuals from maximizing their own welfare, 
and because of an undesirable distribution of health. However, the book also 
addresses interventions that are not solely, or not at all, part of the government 
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policy toolkit. Interventions led by private sector – business or civil society – 
organizations are discussed in several chapters, and evidence of their impacts 
is reviewed alongside that available for government interventions.
Chronic noncommunicable diseases and their prevention
Chronic NCDs are currently the main cause of both disability and death 
worldwide. This heterogeneous group of diseases, including, among others, 
cardiovascular conditions, cancers, chronic respiratory conditions and 
diabetes, affect people of all ages and social classes (WHO 2002). The latest 
global burden of disease estimates indicate that NCDs account for 85 per cent, 
80 per cent and 75 per cent of the global burden of disease, respectively, in 
Western, Central and Eastern Europe. Similarly injuries, particularly on the 
roads or as a result of self- harm, account for a further 10 per cent, 11 per cent 
or 18 per cent of total disease burden (IHME 2013).
Globally, of the 58 million deaths occurring in 2005, approximately 
35 million, or 60 per cent, were due to chronic causes. Most of them were due to 
cardiovascular disorders and diabetes (32 per cent), cancers (13 per cent), and 
chronic respiratory diseases (7 per cent) (Abegunde et al. 2007). This burden is 
predicted to worsen in the coming years. A WHO study projected an increase 
of global deaths by a further 17 per cent in the period 2005–15, meaning that of 
the 64 million estimated deaths in 2015, 41 million people will die of a chronic 
disease (WHO 2005), and NCD deaths would further increase to over 51 million 
in 2030, with three out of four NCD deaths expected in low- and lower- middle- 
income countries.
Chronic diseases and the increased mortality associated with them are not 
distributed evenly across social groups. Those in the most disadvantaged 
socioeconomic conditions typically display higher prevalence and mortality 
rates than those at the opposite end of the social spectrum, with a continuous 
gradient among groups positioned between the two extremes. In countries 
such as Finland, Norway, Denmark, Belgium, Austria and England researchers 
demonstrated a widening of inequalities in premature mortality from 
cardiovascular diseases and many cancers between socioeconomic groups 
(Mackenbach 2006).
The action plan devised by WHO as part of the global strategy for the 
prevention and control of NCDs (WHO 2008) focused on four chronic diseases 
accounting for 60 per cent of deaths worldwide: cardiovascular disease, 
cancer, diabetes, and respiratory disorders. Prominent, yet largely preventable, 
behavioural risk factors associated with these diseases – either directly or 
indirectly via risk factors such as increased blood pressure or cholesterol 
concentrations – include tobacco, harmful alcohol use, unhealthy diets, physical 
inactivity, and obesity. Smoking alone is estimated to be responsible for 
22 per cent of cardiovascular diseases in industrialized countries, and for the 
vast majority of some cancers and chronic respiratory diseases (WHO 2002), 
and is responsible for the loss of 157 million disability- adjusted life- years 
(DALYs) globally (Lim et al. 2012). Alcohol use is associated with a loss of 
75 million DALYs in men and 23 million in women. Overweight and obesity 
6 Promoting Health, Preventing Disease
account for the loss of 94 million DALYs, lack of physical activity for 70 million, 
and high cholesterol for 41 million (Lim et al. 2012).
An economic approach
Health: social determinants or individual responsibility?
The question whether health and health- related behaviours are the result of 
individual choice or external determinants and influences has been at the 
centre of the public health debate for a long time. Opposing views have formed 
on the subject, often linked with different ideological stances.
If health- related behaviours are viewed purely as the result of free choice, the 
case for ‘collective intervention’ is weakened. This may also lead to a culture of 
‘victim- blaming’ (Evans and Stoddart 1994). If, on the other hand, behaviours 
are viewed as individual responses to environmental influences, the focus of 
policy will shifts towards the environmental factors that determine individual 
behaviours. A balanced approach would, of course, recognize that elements 
of free choice coexist and interact with social determinants and influences in 
shaping individual health- related behaviours. Cutler and Glaeser (2005) observe 
that individual characteristics alone are unlikely to explain the uptake of 
health- related behaviours. They found that the correlation of risky behaviours 
in individuals appears to be very low: smokers are unlikely to be also heavy 
drinkers (correlation 12.9 per cent); obesity has virtually no correlation with 
smoking or heavy drinking; the uptake of medical preventive services like 
flu shots or screening is negatively, but very weakly, correlated with risky 
behaviours such as smoking, excess drinking, or having a high body mass 
index (BMI). Cutler and Glaeser also found empirical support for the hypothesis 
that certain ‘situational influences’ are likely to trigger specific lifestyle choices 
in those who are exposed to such influences, with an intensity of response 
that may be modulated by individual characteristics. One such situational 
influence that the same authors explore in some depth is change in food 
production technology. This has been partly responsible for dietary changes 
and for the rise of obesity rates, particularly in individuals and families whose 
time available for meal preparation and cooking has become increasingly 
limited (Cutler et al. 2003). This work lends support to the hypothesis that 
health- related behaviours are primarily determined by interactions between 
individual characteristics and specific environmental influences, rather than 
by the former alone.
If lifestyle choices are the result of environmental influences interacting with 
individual characteristics, then the socioeconomic gradient in lifestyles and 
related health outcomes is likely to reflect differences between individuals in the 
degree of control they have over their own environment. Research conducted in 
the United Kingdom since the 1970s on the relationship between socioeconomic 
position and health (Marmot 2004) underscores the importance of the ability of 
individuals to gain control over their own environment as a crucial determinant 
of the same individuals’ health and health- related behaviours. Evidence is 
becoming available of the role of work- related stress in the relationship between 
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socioeconomic position and health. Stress was shown to be causally associated, 
for instance, with unhealthy lifestyles, the metabolic syndrome and coronary 
heart disease (Chandola et al. 2008). However, the direction of the causal 
relationship remains uncertain. Are individuals predisposed (genetically or by 
other means) to achieving a better control over their own environment also 
able to reach more privileged socioeconomic positions as well as a better health 
status through healthier lifestyle choices, or does a privileged socioeconomic 
position confer better control and healthier lifestyles?
An early and popular model of the determinants of health and health inequalities 
was centred on the individual and on his/her biological characteristics, with 
various ‘layers of influence’ on health (Dahlgren and Whitehead 1991). The latter 
include: individual lifestyle factors; social and community influences; living 
and working conditions; general socioeconomic, cultural and environmental 
conditions. Each of these layers has a direct influence on individual health, 
but interactions between layers contribute significantly to shaping the impact 
of each group of determinants. For instance, ample evidence suggests that 
lifestyle factors, or health- related behaviours, are in turn determined by social 
and community influences, as well as by general socioeconomic, cultural and 
environmental conditions. The existence of a socioeconomic gradient in all 
layers of determinants supports the view that these are closely interconnected. 
Understanding the relationships between layers of influence is as important as 
understanding the direct impact of each layer on individual health. The model 
was adopted as a conceptual basis for a review of health inequalities in the 
United Kingdom in the late 1990s (UK Department of Health 1998).
WHO established a Commission on the Social Determinants of Health in 2005 
to emphasize the role of socioeconomic influences in shaping recent dramatic 
changes in population health patterns and trends at the global level. Wilkinson 
and Marmot (2003) identified ten areas in which solid evidence exists of the 
role of aspects of the social environment on health, elsewhere developed into 
a more extensive inventory of social determinants of health and evidence 
of their impact (Marmot and Wilkinson 2006). The conceptual framework 
developed for the work of the Commission attempts to build an overall model 
of the influences of two main groups of determinants: structural determinants, 
such as the socioeconomic and the political contexts, social structures and 
socioeconomic position; and intermediary determinants, which mediate the 
effect of the former, including biological and behavioural factors, living and 
working conditions, psychosocial factors and health system determinants 
(Solar and Irwin 2007).
The rationale for government intervention in health promotion
An economic approach to prevention involves interpreting health- related 
behaviours as the result of market dynamics leading to the consumption 
of commodities such as tobacco, alcohol, food and physical activity or 
leisure time. Individual choices are subject to many external influences and 
constraints, and are driven by opportunity, costs and other incentives. The 
dynamics, or mechanisms, that help shape our choices about our health- related 
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behaviours are viewed by economists in the same way as market forces that 
influence other choices we make, for instance about the purchase of goods and 
services. This is regardless of whether or not any money changes hands. The 
health determinants that influence our lifestyles are in turn the result of similar 
dynamics.
Sometimes markets fail to operate efficiently. If those failures could be 
avoided, social welfare would be increased. Information failures may contribute 
to the adoption of unhealthy behaviours and lifestyles through an inadequate 
knowledge or understanding of the long- term consequences of such behaviours. 
The negative consequences of the unhealthy behaviours and poor lifestyles of 
any one individual can often have adverse impacts on many other people. The 
harm to public health from excessive alcohol consumption (which can increase 
the risk of domestic abuse and road traffic accidents) is one example of these 
additional impacts, which are referred to by economists as ‘externalities’. 
Externalities may lead to the social costs and benefits of certain forms of 
consumption not being fully reflected in their private costs and benefits to 
individual consumers. For instance, the cost of a bottle of beer may not be high 
enough to fully reflect all the adverse impacts to society of excessive alcohol 
consumption. A biased perception of the importance of future risks may also 
prevent individuals from making choices in their own best interest now.
From an economic perspective, government intervention is justified in the 
presence of significant failures that limit people’s ability to maximize their welfare 
through the market interactions in which they engage. This is largely what 
makes the economic perspective different from the public health perspective. In 
the absence of such significant failures, government intervention would be less 
justified, or not at all. Where market failures exist and have a significant impact, 
the benefits potentially deriving from tackling the inefficiencies they cause may 
sometimes justify some form of corrective action, either by governments or 
other actors, provided such actions are viable and effective. Several economists 
have reviewed potential market failures in relation to chronic diseases and 
prevention (e.g. Kenkel 2000; Cawley 2004; Suhrcke et al. 2006; Brunello et 
al. 2008). A summary of the main failures observed in connection with health- 
related behaviours is provided in the following sections.
Classical market failures: externalities and poor information
Health- related behaviours may entail costs that are not borne by those who 
engage in such behaviours. These spillover effects, or externalities, are a typical 
cause of market failure. Passive smoking is a common example, as it has been 
shown to cause negative health effects on individuals other than the smoker. 
Such effects would not be reflected in the price of cigarettes if this were set in 
a free market between the smoker and the tobacco manufacturer. This means 
that people are more likely to engage in poor behaviours than would be socially 
desirable, given the costs imposed on others. In many cases, these externalities 
can be ‘internalized’ so that the uptake of the behaviours that generate them 
may be brought in line with their actual social costs and benefits, rather than 
with the private costs and benefit experienced by the individual consumers 
themselves. Such measures are generally financial transfers, such as taxes 
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or subsidies, which may be imposed on, or offered to, the consumers or the 
suppliers of the commodity that generates the externality.
The use of taxes and subsidies in the presence of externalities may improve 
the efficiency of market exchanges, but they will also produce distributional 
changes (Sassi et al. 2013). For instance, if a government imposes a tax on a 
form of consumption that generates negative externalities, it may or may not 
be possible, or desirable, for the government in question to redistribute the tax 
revenues raised to those who suffer the consequences of the negative externality 
(which will be diminished by the tax, but not eliminated altogether). Similarly, 
if a commodity that produces positive externalities is subsidized, it may not be 
possible to fund the subsidy by charging those who enjoy the positive external 
effects. From a mere efficiency standpoint, what matters is just that welfare 
gains exceed any losses, but societies are not indifferent to the distribution 
of those gains and losses, therefore governments will have to take this into 
account in assessing the desirability of a policy to address externalities.
Externalities may derive from health- related behaviours such as, for instance, 
tobacco use – through second- hand smoking, violent and disorderly behaviour 
associated with alcohol abuse, or traffic accidents resulting from reckless 
driving. There are also deferred externalities, when people develop risk factors 
and chronic diseases that make them less productive, increase their use of 
medical and social services, which may be publicly funded, or require care 
to be provided by family and friends. Conversely, a reduced life expectancy 
may mean a less prolonged use of publicly funded medical and social services 
at the end of life. In addition to health expenditure and productivity, further 
externalities potentially associated with health- related behaviours can be found 
in the areas of consumption and savings (e.g. reduced consumption associated 
with disease), and education and human capital accumulation (e.g. reduced 
education of family members) (Suhrcke et al. 2006).
A second classical market failure is associated with the lack, or limited 
availability, of sound and reliable information on the costs and benefits of 
health- related behaviours. Information is a critical factor for markets to operate 
efficiently. In order to make rational and efficient choices, consumers have to be 
fully informed about the characteristics and quality of the goods they consume, 
about the benefits (utility) they will derive from consumption, and about the 
opportunity costs they will incur. In the case of health- related consumption 
behaviours, information is often lacking on the nature and the magnitude of 
the associated health risks. Information may be lacking because it does not 
exist (e.g. information on the long- term health effects of the consumption of 
genetically modified crops); because it is concealed or communicated in a 
misleading form by parties that have a vested interest (e.g. information on 
the health effects of smoking withheld by the tobacco industry in the recent 
past); or because it is complex and not easily accessible to the lay person (e.g. 
information on the health risks involved in the consumption of different types 
of fats).
The importance of information in forming health- related beliefs, a first step 
towards influencing lifestyle choices, is shown, for instance, by Cutler and 
Glaeser (2006) in their analysis of the determinants of higher smoking rates 
in Europe compared to the United States of America. The authors reach the 
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conclusion that beliefs were changed in the United States when ‘substantial 
information about the harms of smoking’ was made available to the public, 
while the same information appears to have been communicated less effectively 
in Europe.
The direct provision of information by governments (e.g. health education 
campaigns to influence individual behaviours) or the regulation of information 
(e.g. limits on advertising, guidelines on food labelling) are usually justified by 
limited or imperfect information on the part of the consumer. When information 
failures cannot be fixed, for instance because communication of information 
is difficult, governments may still attempt to compensate for the effects 
of imperfect information by influencing behaviours through appropriate 
incentives (e.g. fiscal incentives like taxes and subsidies).
Behavioural failures
A fast growing body of behavioural economics research has shown that the 
assumption of rationality of the agents involved in market transactions does 
not always reflect the actual behaviours of those agents. Failures of rationality 
may affect the way choices are made, the information upon which choices are 
based, or the preferences that guide those choices. The first aspect includes, 
for instance, the use of heuristics, or rules of thumb, in decision- making. The 
second includes a biased perception of the information available, because the 
way information is presented (framing) influences choices and because of 
cognitive errors in the interpretation of information. The third aspect includes 
inconsistent preferences for outcomes expected at different points in time, or 
for gains and losses.
Detailed studies of heuristics and framing effects are providing valuable 
insights into certain health- related behaviours for designing policies that 
are effective in making those behaviours more conducive to good health. 
Behavioural insights, in particular, have paved the way for new policy 
approaches, including changing default options, increasing the salience of 
the information provided to consumers, and are also helping to refine more 
traditional policy approaches such as regulation (mainly to prevent suppliers 
of health- related commodities from exploiting heuristics and framing effects to 
their own advantage) and taxation (by refining our knowledge of how different 
types of consumers are likely to react to price changes).
Time preferences also play a critical role in health- related behaviours. 
Understanding the way in which people discount future costs and benefits in 
making their lifestyle choices is critical to the design of effective policies to 
counter the possible long- term ill health effects of particular behaviours. A 
large body of empirical literature about time preferences in relation to a variety 
of outcomes, including health (reviewed by Lipscomb et al. 1996), suggests 
that there are no particular reasons for the future health risks associated with 
certain lifestyle choices to be discounted at particularly high, or particularly 
low rates. Some characteristics of those choices, such as the relatively small 
size of the perceived health risks involved, will make people discount more 
heavily those future risks. But other characteristics of the same choices will 
have the opposite effect.
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Substantial empirical evidence shows that individual health- related 
behaviours often reflect hyperbolic discounting. This refers to an accelerated 
form of discounting, which heavily penalizes future outcomes in present 
judgements in a way that makes time preferences inconsistent. This is 
essentially a self- control problem. Take, for instance, an obese person who is 
perfectly aware of the long- term health risks associated with her condition. 
She may decide that such risks are offset by the pleasure she derives from her 
dietary habits and sedentary lifestyle at present, therefore she will choose to 
postpone quitting her habits. Procrastination is a key feature of hyperbolic 
discounting. She perceives this as a postponement because she feels that 
after some time (say, in one year) she will no longer value pleasure from her 
current lifestyle more highly than the long- term health risks associated with it. 
She is convinced that a year later she will be prepared to change some of her 
dietary and activity behaviours. However, after one year she will find herself 
discounting future health risks more heavily than she previously thought she 
would do, and she will still feel that the pleasures of her lifestyle offsets future 
health risks. Inconsistency in time preferences is reflected by the discrepancy 
between the way the individual originally thought she would discount future 
outcomes and the way she actually discounted them one year later. The result 
is a likely indefinite postponement of the decision to quit current habits. At least 
some evidence of hyperbolic discounting has been found in relation to obesity, 
one study reported that ‘time inconsistent preferences regarding weight is a 
very common problem among teenagers, since the majority of them end up 
failing to reduce their BMI after having declared to be trying to lose weight’ 
(Brunello et al. 2008).
Paternalistic government intervention to counter self- control problems would 
require ‘tricky social welfare decisions’, or a judgement of whether individuals’ 
future self, or long- term preferences, should be given priority over their present 
self, or short- term preferences (Glaeser 2006). Such problems, in Glaeser’s view, 
are best addressed by increasing the availability of ‘technologies or contracts 
that facilitate private self- control’. An example could be the fiscal deductibility 
of private expenditures on devices that may facilitate self- control (e.g. 
nutrition advice, organized physical activities, etc.), or coverage of nicotine 
replacement therapies to aid smoking cessation. The latter measures, which 
essentially broaden individual choice, are often viewed as non- paternalistic 
interventions, as discussed in the section, ‘Chronic noncommunicable diseases 
and their prevention’, although in fact they do interfere with individual choice, 
and they may involve a significant cost, to be shared among all social groups 
when interventions are publicly funded.
Government intervention may also be justified when health- related 
behaviours are addictive, or habit- forming. This may happen because the 
commodities involved may generate forms of chemical dependence that make 
it difficult for individuals to quit consuming them, as is the case with many 
drugs, or because of psychological mechanisms that encourage the reiteration 
of consumption. The term ‘habit’ is generally used in relation to the latter, 
while the term ‘addiction’ is applied more widely, both in relation to drugs or 
tobacco smoking (which involves a certain degree of dependence on nicotine) 
and in relation to consumption that does not involve chemical dependence (e.g. 
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gambling addiction). It is the non- independence of these acts of consumption, 
as they may be influenced by previous consumption experiences, which may 
cause concern about individuals’ ability to maximize their welfare. The presence 
of a chemical dependence may strengthen the justification for intervention, but 
some forms of psychological addiction may also be extremely powerful and 
potentially damaging. Forms of consumption involving interdependent choices 
over time are sometimes interpreted in economics as rational addictions, 
based on models originally proposed by Becker and Murphy (1988), strongly 
supported by empirical evidence (e.g. Chaloupka and Warner 1999).
Habit- forming behaviour is consolidated behaviour in which individuals 
engage over a prolonged period of time and from which they find it difficult 
to wean themselves. Habits typically involve a reduced motivation to seek and 
use information that may lead to a better understanding of the consequences 
of the behaviour in question, and to a tendency to discount the value of new 
information that is received, particularly when it highlights risks associated with 
the habitual behaviour. In addition, people who engage in habitual behaviour 
act on the implicit assumption that if they found the behaviour desirable when 
they first adopted it, it must also be desirable for them to continue to engage in 
the same behaviour (Maio et al. 2007). Consumers take up habits because they 
find it convenient to do so, but habits may prevent them from maximizing their 
own welfare.
Equity and health
A further factor that may contribute to justifying government intervention is 
an undesirable distribution of social welfare, of which health is an important 
component. Evidence of significant disparities in health status and longevity 
has been available for several decades in many countries, and governments 
have made commitments to reduce major disparities in health on equity 
grounds. Concepts of equity adopted by national governments and international 
organizations in relation to health often focus on health care and tend to be 
centred on notions of equality with respect to some relevant dimension, a 
common example being equal access for equal need. However, even when 
the focus is narrowly placed on health care, policy decisions are sometimes 
inconsistent with regard to their distributional effects and the balance they 
achieve between the goals of equity and efficiency (Donaldson and Gerard 
1993; Sassi et al. 2001). Approaches to promoting equity with regard to health 
status have been more cautious, generally avoiding direct references to notions 
of equality, and rather focusing on the reduction of variations across population 
groups.
There is generally recognition that health disparities are likely to persist as 
long as social structures allow some degree of inequality. It has been argued 
that health inequalities, at least to a certain extent, are acceptable, or even 
desirable (Collison 1988), because of trade- offs between equity and efficiency, 
non- modifiable risk factors (for example, genetic heritage) and individual 
choice (driving, at least to some degree, health- related behaviours). The 
question for governments is what health inequalities should be tackled, and 
how much effort should be put into redressing them.
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Prevention is bound to have distributional impacts. Different individuals and 
groups have different probabilities of developing chronic diseases, and have 
different outcomes once such diseases occur. Different individuals and groups 
also respond differently to preventive interventions. Potential distributional 
effects cannot be ignored in the design of preventive interventions. Not only 
should they be accounted for, but they can be openly pursued, in line with the 
distributional objectives of health and broader government policy. Prevention 
offers excellent opportunities for redistribution of health and longevity. 
Prevention strategies are not subject to the same moral imperative of health 
care, and may be more easily targeted to those individuals and groups who are 
deemed to need and deserve them the most. Chapter 12 provides an analysis of 
how alternative health promotion and disease prevention policies may impact 
on the distribution of health and social welfare.
Forms of government intervention in health promotion
Government interventions in health promotion and disease prevention have 
a significant potential for improving health, but will also interfere, at least to 
some degree, with individual choices and behaviours.
The least intrusive interventions are those aimed at widening choice by 
expanding the range of options individuals can choose from, or those aimed 
at making certain existing options more affordable. Persuasion and other non- 
price devices such as default rules are often advocated as minimally intrusive 
interventions which do not significantly affect rational consumers. However, 
governments may not always deliver persuasion effectively and in the best 
interest of individuals, and it is difficult to monitor whether they do so. Taxes 
and consumption bans are more transparent and contestable, although they may 
lead to welfare losses when consumers display varying degrees of rationality. 
Taxation models targeting the least rational consumers may be possible, but 
their development is still at a very early stage. Outright bans of selected choice 
options involve the highest degree of interference with individual choice. They 
may be difficult to enforce, particularly when demand is strong or consumption 
is addictive.
Heavier interference with individual choices may be justified when 
departures from rational decision- making and from an ideal efficient market 
model for lifestyle choices are significant, or when the consequences of those 
departures are particularly severe. The political costs of prevention, in the form 
of interference with individual choice, often follow an inverse pattern relative 
to the economic costs. Interventions that involve lower degrees of interference 
tend to have higher economic costs, and vice versa.
Actions that widen choice or make certain options more accessible are 
generally well accepted, despite the objections of some critics and their mild 
interference with free market interactions. These actions include support 
to access technologies that help private self- control. Opportunities for adopting 
actions of these types find their main limits in their financial costs, their 
efficiency and distributional implications. The use of actions involving higher 
levels of interference with individual choice may be met with increasing 
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degrees of hostility, especially when only certain forms of consumption of 
a commodity are unhealthy and consumers differ in terms of the nature of their 
consumption. These actions become more appropriate when the consumption 
of a commodity is invariably unhealthy and bears a large potential for self- 
harm; in the presence of important classical market failures, particularly 
externalities; when actions may be targeted to population groups at the upper 
extreme of the bounded rationality spectrum (e.g. children, whose early life 
experiences and behaviours appear to contribute significantly to the formation 
of their long- term tastes and preference for food and drink, as well as their 
participation in physical activity) or groups that are particularly exposed to 
external influences that may trigger unhealthy behaviours (e.g. disadvantaged 
socioeconomic groups).
Whole- of- government and whole- of- society approaches
Health promotion and disease prevention policies are by no means confined to 
the health care sector. A large number of polices typically developed in other 
areas of government action may have an impact on health- related behaviours 
and, ultimately, on the health of a population. For instance, agricultural policies 
adopted in most countries, often based on taxes and subsidies, may change 
the relative prices of healthy foods, such as fruit and vegetables, as well as 
less healthy foods, such as those high in fat and sugar. Town planning, the 
design of the built environment and traffic regulation may provide incentives 
or disincentives for active transport (such as walking and cycling) as opposed 
to inactive (vehicular) transport. More generally, there is growing evidence 
that commodities like education, often delivered through public programmes, 
or at least publicly financed, may be positively associated with health, partly 
through their effects on lifestyle choices.
This book takes a whole- of- government approach, recognizing that public 
health policies must be developed across different sectors of government 
intervention, and that a sound and effective health promotion strategy must 
address policies in most areas of government intervention, which have potential 
consequences on population health. This approach, and the challenges it 
involves, are discussed in detail in Chapter 14.
Health promotion and disease prevention, however, are not an exclusive 
domain of government action either. Certain types of actions, particularly 
those aimed at widening choice, lowering the prices of certain choice options, 
influencing choices through persuasion, and even some regulatory actions, may 
be promoted or undertaken by actors other than governments, acting alone or 
in cooperation with governments. These actors may be as diverse as groups 
of individuals organized for the pursuit of special or general interests (e.g. 
community action groups, patient organizations, trade unions); professional 
and business organizations; research organizations and think tanks; civil 
society organizations; or the mass media. The importance of non- governmental 
action is underscored, for instance, by a comparative analysis of trends in 
smoking rates in the United States and Europe, discussed previously under the 
heading, ‘Classical market failures: externalities and poor information’, which 
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shows that information was conveyed more effectively in the United States 
thanks to the entrepreneurial action of anti- smoking interest groups (Cutler 
and Glaeser 2006).
Disparate motives may lead non- government actors to engage in actions 
aimed at influencing individual consumption choices in the best interest of 
consumers. Organized groups of individuals (e.g. consumer groups) may 
be particularly motivated to take action in situations of asymmetric market 
power, i.e. markets in which supply may be relatively concentrated, or in 
which information may be asymmetrically distributed between consumers and 
suppliers. In the absence of government intervention, because governments do 
not wish to interfere or intervention would be inefficient, consumers, or other 
individuals who care for their interests, may attempt to strengthen their position 
through organized actions. Professional organizations are a special case of 
such groups, particularly when professionals act as agents of consumers in 
the protection of their health, as with public health or medical professionals. 
Businesses may engage in the production and commercialization of healthy 
commodities whenever market opportunities emerge, but they will also engage 
in the production and commercialization of unhealthy, or potentially unhealthy, 
commodities when a market for these can be established. In the latter case, 
business organizations may be motivated to seek deviations from market 
dynamics in the best interest of consumers under the threat of tougher actions 
by other subjects, especially governments, which may affect the interests of 
their own members. For instance, business organizations may decide to adopt 
voluntary self- regulation schemes to pre- empt more cogent regulatory actions 
by government. Employers may, individually or collectively, promote lifestyle 
interventions for their own employees with a view to improving the overall 
health of the workforce and increasing productivity, or as part of a ‘social 
contract’ with workers. Health insurance organizations, again individually or 
collectively, may find that lifestyle change and prevention may provide the 
means for containing health expenditures by raising average levels of health in 
the pool of insurees. Research organizations, think tanks and the mass media 
often act as watchdogs on market dynamics and other social phenomena, and in 
this capacity they may be motivated to take action in the interest of consumers. 
Actions like those envisaged so far may purportedly be in the best interest of 
consumers, but even when in good faith, the actors who promote those actions 
may be prone to influences, biases, and other limitations of rationality that may 
cause the outcomes of such actions to deviate from their original goals.
The roles played by non- government actors are potentially very important 
in determining the success of complex preventive interventions. Unilateral 
actions by governments or others may often prove ineffective or impossible 
if other actors are not fully engaged in the design and implementation of 
such actions. In most cases, health promotion and disease prevention require 
sacrifices on the part of some of the actors involved, which may well be offset 
by the health benefits of prevention, but nevertheless must be understood 
and accepted by those who will have to bear them. Direct participation in the 
development of preventive interventions by all those who have a stake in the 
process is increasingly regarded as a pre- condition for successful prevention 
policies.
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The structure of the book and remaining chapters
The first chapters of the book (2 and 3) are meant to provide a detailed view of 
the economic approaches available for the evaluation of policy interventions 
in the areas of health promotion and disease prevention. These include both a 
discussion of basic concepts and theories, and a practical illustration of methods 
and measures of cost and outcome that are typically used in such evaluations. 
Chapters 2 and 3 are intended to provide readers with the tools to interpret the 
evidence reviewed in the rest of the book, and also to offer guidance to those 
who intend to contribute to the economic evidence base on health promotion 
and chronic disease prevention.
The next set of chapters (4 to 10) represents the core of the book, and 
contains detailed reviews and analyses of the economic evidence available in 
specific risk factor areas. In particular, chapters 4 to 7 address behavioural risk 
factors (tobacco smoking, harmful alcohol use, physical inactivity and 
unhealthy diets), while Chapter 8 covers selected environmental risk factors, 
Chapter 9 road traffic injuries, and Chapter 10 mental health risk factors 
and conditions. The main findings of these chapters are also presented in a 
Policy Summary jointly published by the European Observatory and the 
Organisation for Economic Co- operation and Development (OECD) in 
December 2013.
The next four chapters address cross- cutting themes, including intervention on 
selected social determinants of health, with a focus, in particular, on education 
and early life interventions (Chapter 11); the distributional implications of 
policy actions in health promotion and disease prevention (Chapter 12); key 
implementation issues (Chapter 13) and cross- sectoral challenges (Chapter 14). 
Chapter 15 provides overall conclusions from the evidence presented in the 
rest of the book. A series of summary tables provides a critical appraisal of 
the evidence available on specific types of interventions, summarizing the key 
contents of chapters 4 to 10. These tables can be found in the Policy Summary 
(Merkur et al. 2013: 48- 72).
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